Literature DB >> 30149185

The utility of artificial neural networks and classification and regression trees for the prediction of endometrial cancer in postmenopausal women.

V Pergialiotis1, A Pouliakis2, C Parthenis3, V Damaskou3, C Chrelias3, N Papantoniou3, I Panayiotides2.   

Abstract

OBJECTIVE: Artificial neural networks (ANNs) and classification and regression trees (CARTs) have been previously used for the prediction of cancer in several fields. In our study, we aim to investigate the diagnostic accuracy of three different methodologies (i.e. logistic regression, ANNs and CARTs) for the prediction of endometrial cancer in postmenopausal women with vaginal bleeding or endometrial thickness ≥5 mm, as determined by ultrasound examination. STUDY
DESIGN: We conducted a retrospective case-control study based on data from analysis of pathology reports of curettage specimens in postmenopausal women.
METHODS: Classical regression analysis was performed in addition to ANN and CART analysis using the IBM SPSS and Matlab statistical packages.
RESULTS: Overall, 178 women were enrolled. Among them, 106 women were diagnosed with carcinoma, whereas the remaining 72 women had normal histology in the final specimen. ANN analysis seems to perform better with a sensitivity of 86.8%, specificity of 83.3%, and overall accuracy (OA) of 85.4%. CART analysis did not perform well with a sensitivity of 78.3%, specificity of 76.4%, and OA of 77.5%. Regression analysis had a poorer predictive accuracy with a sensitivity of 76.4%, a specificity of 66.7%, and an OA of 72.5%.
CONCLUSION: Artificial intelligence is a powerful mathematical tool that may significantly promote public health. It may be used as a non-invasive screening tool to guide clinicians involved in primary care decision making when endometrial pathology is suspected.
Copyright © 2018 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ANN; CART; Endometrial cancer; Neural network; Prediction

Mesh:

Year:  2018        PMID: 30149185     DOI: 10.1016/j.puhe.2018.07.012

Source DB:  PubMed          Journal:  Public Health        ISSN: 0033-3506            Impact factor:   2.427


  7 in total

Review 1.  Advances in the Preoperative Identification of Uterine Sarcoma.

Authors:  Junxiu Liu; Zijie Wang
Journal:  Cancers (Basel)       Date:  2022-07-20       Impact factor: 6.575

2.  Validation of the usefulness of artificial neural networks for risk prediction of adverse drug reactions used for individual patients in clinical practice.

Authors:  Shungo Imai; Yoh Takekuma; Hitoshi Kashiwagi; Takayuki Miyai; Masaki Kobayashi; Ken Iseki; Mitsuru Sugawara
Journal:  PLoS One       Date:  2020-07-29       Impact factor: 3.240

3.  Management of imported malaria cases and healthcare institutions in central China, 2012-2017: application of decision tree analysis.

Authors:  Xi-Liang Wang; Jie-Bin Cao; Dan-Dan Li; Dong-Xiao Guo; Cheng-Da Zhang; Xiao Wang; Dan-Kang Li; Qing-Lin Zhao; Xiao-Wen Huang; Wei-Dong Zhang
Journal:  Malar J       Date:  2019-12-18       Impact factor: 2.979

Review 4.  Progress of Artificial Intelligence in Gynecological Malignant Tumors.

Authors:  Jie Zhou; Zhi Ying Zeng; Li Li
Journal:  Cancer Manag Res       Date:  2020-12-14       Impact factor: 3.989

5.  Prediction of Endometrial Carcinoma Using the Combination of Electronic Health Records and an Ensemble Machine Learning Method.

Authors:  Wenwen Wang; Yang Xu; Suzhen Yuan; Zhiying Li; Xin Zhu; Qin Zhou; Wenfeng Shen; Shixuan Wang
Journal:  Front Med (Lausanne)       Date:  2022-03-04

6.  Risk factors and the utility of three different kinds of prediction models for postoperative fatigue after gastrointestinal tumor surgery.

Authors:  Xin-Yi Xu; Jin-Ling Lu; Qin Xu; Hong-Xia Hua; Le Xu; Li Chen
Journal:  Support Care Cancer       Date:  2020-04-26       Impact factor: 3.603

7.  Combining genetic risk score with artificial neural network to predict the efficacy of folic acid therapy to hyperhomocysteinemia.

Authors:  Xiaorui Chen; Xiaowen Huang; Diao Jie; Caifang Zheng; Xiliang Wang; Bowen Zhang; Weihao Shao; Gaili Wang; Weidong Zhang
Journal:  Sci Rep       Date:  2021-11-02       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.